Cemhan Biricik, CEO of Fast Lab Technologies, and Martin Perlin, its medical director, are alleged to have billed public and private payors for testing that was never done.

The laboratory medicine organization is focused on the benefits of using data science within laboratories to more effectively care for patients and track utilization.

The firm expects to see growth in its life science business, in particular after it showed positive signs during the second quarter.

Danaher subsidiaries Beckman Coulter, Cepheid, and Leica Biosystems will be working together with external partners to focus on existing disease areas.

Stakeholders suggested that while the FDA rule is dead, updates to LDT regulation are coming nonetheless, and the industry should play a lead role in developing them.

The new BD Onclarity HPV test would enable patients to collect a sample without the need for liquids or other devices and mail it to the laboratory for testing.

Danaher subsidiaries Beckman Coulter, Cepheid, and Leica Biosystems will be working together with external partners to focus on existing disease areas.

The company reported 5 percent growth in Europe and 3 percent growth in North America, while its revenues in the rest of the world dipped 2 percent.

China's volume-based procurement policy and US tariffs have forced companies with large businesses in China to reset their ...

The funding supports development of an assay to detect and differentiate H5 influenza A from seasonal H1 and H3 subtypes, flu B, and COVID-19.

Diagnostics revenue totaled €1.06 billion in Q3 compared to €1.11 billion a year ago, down 4 percent or a fraction of a percent on an adjusted basis.